The clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationCarolina Q. Sacramento, Thiago Moreno L. Souza, André C. Ferreira et al.|Scientific Reports|2017Cited by 243
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelaeAndré C. Ferreira, Thiago Moreno L. Souza, Camila Zaverucha-do-Valle et al.|Scientific Reports|2017Cited by 115
Beyond Members of the <i>Flaviviridae</i> Family, Sofosbuvir Also Inhibits Chikungunya Virus ReplicationAndré C. Ferreira, Thiago Moreno L. Souza, Patrícia A. Reis et al.|Antimicrobial Agents and Chemotherapy|2018Cited by 98
The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replicationCaroline Q. Sacramento, Thiago Moreno L. Souza, Gabrielle R. de Melo et al.|bioRxiv (Cold Spring Harbor Laboratory)|2016Cited by 25